PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.17
ESG score 90-95% of INKT's 63.31. Bill Ackman would demand clear ESG improvement catalysts.
58.08
Environmental score 1.1-1.2x INKT's 50.77. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
59.30
Social score 80-90% of INKT's 73.94. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.13
Governance score 90-95% of INKT's 65.21. Bill Ackman would demand clear governance improvement catalysts.